FDA orphan drug designation: treatment of hereditary angioedema
All entries for: ADARx Pharmaceuticals Inc.
October 2, 2025
ADARx Pharmaceuticals Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of hereditary angioedema
